ENDRA Life Sciences (NDRA) Other Non-Current Assets (2020 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Other Non-Current Assets of $5986.0 for Q1 2026, little changed YoY from $5984.0 in Q1 2025, and little changed sequentially from $5986.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
ENDRA Life Sciences has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $5986.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed 0.03% year-over-year to $5986.0; the TTM figure through Mar 2026 stood at $5986.0 (changed 0.03% YoY), while the FY2025 annual figure was $5986.0, down 98.36% from the prior year.
- Other Non-Current Assets held at $5986.0 in Q1 2026, from $5986.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for NDRA reached as high as $647085.0 in Q1 2024 and fell as low as $5984.0 in Q1 2025.
- The 5-year median for Other Non-Current Assets is $5986.0 (2022), against an average of $175666.6.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets jumped 10709.97% — and 2025, when it plunged 99.08%.
- A 5-year view of Other Non-Current Assets shows it stood at $5986.0 in 2022, then changed by 0.0% to $5986.0 in 2023, then jumped by 6004.53% to $365417.0 in 2024, then sank by 98.36% to $5986.0 in 2025, then changed by 0.0% to $5986.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $5986.0, $5986.0, and $365417.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 498.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 5.97 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 4.21 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 552.79 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 51.00 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 1.18 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 489.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 523.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 454.16 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | 5,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,986.00 |
| Dec 31, 2025 | 5,986.00 |
| Sep 30, 2025 | 365,417.00 |
| Jun 30, 2025 | 365,417.00 |
| Mar 31, 2025 | 5,984.00 |
| Dec 31, 2024 | 365,417.00 |
| Sep 30, 2024 | 5,986.00 |
| Jun 30, 2024 | 647,085.00 |
| Mar 31, 2024 | 647,085.00 |
| Dec 31, 2023 | 5,986.00 |
| Sep 30, 2023 | 5,986.00 |
| Jun 30, 2023 | 530,068.00 |
| Mar 31, 2023 | 5,986.00 |
| Dec 31, 2022 | 5,986.00 |
| Sep 30, 2022 | 5,986.00 |
| Jun 30, 2022 | 5,986.00 |
| Mar 31, 2022 | 5,986.00 |
| Dec 31, 2021 | 5,986.00 |
| Sep 30, 2021 | 5,986.00 |
| Dec 31, 2020 | 5,986.00 |